Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH)   SPRING 2003 , Volume 8 , Number 1 (31); Page(s) 31 To 34.
 
Paper: 

BOTULINUM TOXIN A AND FOCAL HYPERHYDROSIS

 
 
Author(s):  AHMADI F.*, SHAHAMI GH.A., GACHKAR L., NIAKAN R.
 
* Department of Dermatology shaheed Beheshti University of Medical sciences
 
Abstract: 

Background: Focal hyperhydrosis is a common disease with unknown etiology. There are some therapeutic approaches, all of which are relatively ineffective of even accompany side effects. Botulinum toxin A was introduced as an effective therapy some years age, however we lack any informative data in our country, thus the present study was conducted in Loghman Hakim Hospital in 2001.
Materials and methods: For this clinical trial, 32 patients with focal hyperhydrosis were included. Palm, sole and auxiliary regions were affected in 20, 5, and 7 patients, respectively. Botulinum toxin A was injected intradermally.
Results: of 32 patients, 31 (96.9%) have responded to our intervention. Transient weakness of hand was reported in 9 patients.
Conclusion: Intradermal Botulinum toxin A is an effective, stable therapeutic approach for patients with focal hyperhydrosis. Further studies are highly recommended.

 
Keyword(s): FOCAL HYPERHYDROSIS, BOTULINUM TOXIN A
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 166
 
Latest on Blog
Enter SID Blog